This week Kitty and Dr. Fallon will host their No Sugar Added™ “open forum.” Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00 pm ~ 9:00 pm (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092.
Photo Above: Kitty Castellini & Dr. Joseph J. Fallon, Jr.
This week Kitty and Dr. Fallon will interview Dr. Joseph P. Costabile, Vascular Surgeon from Virtua Surgical Group. Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00 pm ~ 9:00 pm (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092.
Dr. Joseph P. Costabile grew up in North Jersey and graduated from The Pingry School in 1972. He attended college at Ohio Wesleyan University and graduated with a B.A. in 1976 with majors in both Chemistry and Bacteriology. Dr. Costabile subsequently graduated from UMDNJ, RutgersMedical School, Camden in 1986. Dr. Costabile stayed on at Cooper Hospital for his General Surgery Internship and residency. Upon completing his General surgery training, Dr. Costabile then did a trauma fellowship at Cooper hospital’s trauma center until 1992. Dr. Costabile completed a Vascular surgery fellowship at Robert Wood Johnson University Hospital, New Brunswick, N.J. in 1995 and then rejoined the faculty at Cooper hospital from 1995 until 1998. Dr. Costabile joined Surgical Group of South Jersey in 1998 until the present. Dr. Costabile is involved with the United States Navy Reserves and has a commission as an officer and general/trauma and vascular surgeon. Dr. Costabile has also completed two tours of duty in Kuwait and Iraq in 2005 and 2008 respectively. Dr. Costabile is very proud to serve our nation and our men and women in uniform. His areas of interest in vascular surgery are venous disease, endovascular surgery and wound care. His hobbies are fishing, skiing and fitness training. Dr. Costabile is married to Yolanda for the past eleven years, but as she puts it only nine years together, due to his overseas deployments.
Photo Above: Dr. Joseph P. Costabile
TARRYTOWN, NY (September 21, 2009)- Bayer Diabetes Care today announced U.S. Food & Drug Administration clearance to market the CONTOUR® USB blood glucose meter. Bayer’s CONTOUR USB is the first and only blood glucose monitor that plugs directly into a computer providing users with instant access to information that can help optimize diabetes management. The CONTOUR USB meter is integrated with GlucofactsTM DELUXE software for easy retrieval of data as well as longer-term tracking and analysis of blood glucose test results.
Bayer’s CONTOUR USB meter is a cutting edge, premium meter that connects directly to a PC or MAC and the meter can store up to 2,000 test results. The built-in USB technology allows patients to simply plug in to gain knowledge about trends and patterns in their blood glucose levels.
Ongoing data tracking and accurate information sharing are key to good diabetes management. The CONTOUR USB meter facilitates data organization and management - transforming results into meaningful insights that healthcare professionals and their patients can readily discuss.
“This is an ideal blood glucose monitor for patients who are highly engaged in managing their diabetes, particularly those on insulin who must test frequently,” said David Simmons, MD, chief medical officer for Bayer Diabetes Care. “With the CONTOUR USB meter, patients are able to review their results with their healthcare professional during an office visit, over the phone, or via email, giving them the opportunity to make treatment adjustments, such as taking action to reduce their A1C levels, if necessary.”
Measurement of A1C provides an average assessment of blood sugar levels over the past three months - and is an indicator of how well diabetes is being controlled over the longer term. Studies have shown that routine tracking of blood glucose can help patients better manage their blood sugar and may result in a lower A1C level, which is important for consistent diabetes management. In fact, even a one-percent reduction in A1C reduces the risk of serious complications by 40 percent.
Bayer’s CONTOUR USB meter features:
· A bright color display screen visible in any light that shows average, high and low readings with
· Customizable features such as intuitive pre- and post-meal marking
· 500MB extra memory for storage of personal diabetes information
· Rechargeable battery that can charge from any USB port or via the CONTOUR USB wall charger provided
· GlucofactsTM DELUXE diabetes management software (use of Bayer’s diabetes management software has been shown to significantly lower A1C and a sustained A1C reduction could lead to potential cost savings.)
The CONTOUR USB meter is based on Bayer’s trusted CONTOUR system, providing the same easy accuracy, No CodingTM technology, no interference with maltose, galactose, and oxygen and automatic correction for hematocrit and common interfering substances (e.g. acetaminophen, ascorbic acid), as well as a 5-second test time and small (0.6 µL) sample size - all helping to simplify life with diabetes. The CONTOUR USB meter uses CONTOUR blood glucose test strips currently available for other CONTOUR meters.
Nick Jonas of The Jonas Brothers, who has diabetes and is a diabetes ambassador for Bayer, said, “I already use Bayer’s CONTOUR meter to monitor my blood glucose and my doctor always talks about how important it is to track my results. I am excited to try out the new CONTOUR USB meter, because I can plug it in to a computer from wherever I am to get the information I need to manage my diabetes.”
Bayer’s CONTOUR USB meter will soon be available for sale in the U.S. For more information, visit www.BayerContourUSB.com or www.simplewins.com.
About Diabetes
Diabetes is a disease in which the body does not produce or properly use insulin. Approximately 23.6 million children and adults in the United States have diabetes, which puts them at risk for developing serious health complications over time, such as heart disease, kidney disease, blindness, and stroke. Type 1 diabetes, also called juvenile diabetes, is usually diagnosed in children and young adults. In persons with type 1 diabetes, the body makes little or no insulin, which may result in many complications if glucose levels are not controlled. Type 2 diabetes is usually diagnosed in adults, although increasingly, children are being diagnosed with this disease. Type 2 is associated with obesity, family history of diabetes, history of gestational diabetes, impaired glucose metabolism, physical inactivity, and race/ethnicity.
Bayer Diabetes Care
Bayer Diabetes Care, is a worldwide leader in diabetes, supporting customers in 100 countries, and for more than 40 years, has led the way in diabetes care product innovation. Bayer introduced the first portable blood glucose meter and test strips, innovated the measurement of A1C (glycated hemoglobin) with A1CNow+® and A1CNow®SELFCHECK and was the first to offer a suite of blood glucose monitors (CONTOUR® and BREEZE®2). Certain features of Bayer’s blood glucose monitors such as No Coding technology and no interference from maltose and galactose make diabetes management easier. Today, Bayer Diabetes Care offers an unparalleled choice in diabetes management systems and comprehensive support including education, tools and resources designed to simplify life with diabetes.
Bayer Diabetes Care is a business of the Bayer HealthCare LLC, Medical Care Division and has its global headquarters located in Tarrytown, New York. For more information visit www.bayerdiabetes.com or in the U.S. www.simplewins.com.
Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals
divisions. The pharmaceuticals business operates under the name Bayer Schering
Pharma. Bayer HealthCare’s aim is to discover and manufacture products that will
improve human and animal health worldwide. Find more information at www.bayerhealthcare.com
This week Dr. Fallon and “guest co-host” Dr. Steven Kaufman (filling in for Kitty) will interview Cardologist Dr. Elias A. Iliadis from Cooper University Hospital. Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00 pm ~ 9:00 pm (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092.
Dr. Kaufman graduated with a Bachelor of Arts degree in Psychology from Rutgers University in New Brunswick. He attended medical school at Temple University School of Medicine. He completed his internal medicine residency at Case Western Reserve University, and a fellowship in endocrinology and metabolism at the University of Pittsburgh. He is an assistant professor of Medicine at Cooper University Medical Center and Robert Wood Johnson School of Medicine and Dentistry. He practices clinical endocrinology, regularly teaches medical students, interns and residents, and is a regular contributor to medical journals. Dr. Kaufman is the co-principle investigator of the Camden Citywide Diabetes Collaborative. This multipronged, citywide effort aims to improve diabetes care at the patient, practice, and community level within Camden.
His hobbies include playing with his family, running marathons and reading non-fiction books.
Photo Above: Dr. Steven Kaufman
Clinical Cardiologist Elias A. Iliadis, M.D., will answer your questions about diagnosis and treatment for PVD, and heart disease. Dr. Iliadis is Medical Director of Noninvasive Vascular Intervention, Cooper Heart Institute; Director of the Cardiac Catheterization Laboratory at Memorial Hospital of Salem County; and Assistant Professor of Medicine, UMDNJ-RWJMS at Camden. He is board certified in Internal Medicine in three and two cardiology specialties Cardiovascular Disease, and Interventional Cardiology and Internal Medicine. Dr. Iliadis graduated from UMDNJ - Robert Wood Johnson Medical School and completed an internship and residency at Thomas Jefferson University Hospital in Philadelphia, Pa. He completed his fellowship training in cardiology was a Fellow at the University of Michigan Medical Center.
Dr. Iliadis’ special interests include: coronary artery disease and intervention, heart attack care, peripheral vascular disease and intervention, nuclear cardiology and noninvasive vascular disease assessment. He sees patients in his office in Voorhees.
Photo Above: Dr. Elias A. Iliadis
This week Kitty and Dr. Fallon will interview Endocrinologist Dr. Kevin Furlong from Jefferson Medical College. Listener’s are invited to call in with their questions and comments. Tuesday Evening 8:00 pm ~ 9:00 pm (EST) Cruisin 92.1 FM~WVLT, streaming live on the web at www.wvlt.com Call In: 856-696-0092.
Dr. Furlong graduated with a Bachelor of Science degree in Business Administration from Drexel University and a Bachelor of Science degree in Pharmacy from the Philadelphia College of Pharmacy and Science. He attended medical school at the University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine and completed his internal medicine residency and fellowship in endocrinology at Thomas Jefferson University. Currently, he is an assistant professor of medicine at Jefferson Medical College where he teaches medical students, interns, residents and fellows. He has won many teaching awards and is listed as one of the top internal medicine teachers for the Thomas Jefferson University residency program. In addition, he is also director of inpatient endocrinology services at Jefferson hospital.He is principle investigator on many clinical trials related to diabetes and obesity. In addition he has written many articles and lectures extensively on diabetes and obesity.
His hobbies include playing with his family, working out, playing golf , tennis and playing drums.
Photo Above: Dr. Kevin Furlong
